TY - JOUR
T1 - Multicenter survey of in vitro antifungal resistance in yeasts of medical importance isolated from Spanish patients
AU - Quindós, Guillermo
AU - Abarca, Lourdes
AU - Carrillo-Muñoz, Alfonso J.
AU - Arévalo, Ma Pilar
AU - Bornay, Fernando J.
AU - Casals, José B.
AU - Hernández Molina, Juan Manuel
AU - Iglesias, Isabel
AU - Linares, Ma José
AU - Martín-Mazuelos, Estrella
AU - Ferreirós, Manuel Pereiro
AU - Rezusta, Antonio
AU - Rubio, Ma Carmen
AU - Salesa, Ricardo
AU - Millán, Rosario San
AU - Torres-Rodríguez, Josep M.
PY - 1999/6/1
Y1 - 1999/6/1
N2 - Twelve Spanish laboratories collected 325 yeast clinical isolates during a 30 day's period, among them 224 Candida albicans, 30 Candida glabrata, and 27 Candida parapsilosis. In vitro antifungal susceptibility to amphotericin B, ketoconazole, fluconazole and itraconazole was determined by an agar diffusion test (Neo-Sensitabs®, Rosco, Denmark). All the isolates tested were susceptible in vitro to amphotericin B and nearly all (97.2%) to itraconazole. In vitro susceptibility to fluconazole and ketoconazole was high (90.2% and 91.4% of isolates, respectively) but showed variations depending on the species tested. Resistance to fluconazole and ketoconazole was low in C. albicans (4% and 3%, respectively), but 30% of Candida guilliermondii and 36% of C. glabrata isolates were resistant to fluconazole. Ketoconazole resistance was observed in 40% of C. glabrata, and 17% of Candida tropicalis. Resistance to antifungal drugs is very low in Spain and it is related to non-C. albicans isolates.
AB - Twelve Spanish laboratories collected 325 yeast clinical isolates during a 30 day's period, among them 224 Candida albicans, 30 Candida glabrata, and 27 Candida parapsilosis. In vitro antifungal susceptibility to amphotericin B, ketoconazole, fluconazole and itraconazole was determined by an agar diffusion test (Neo-Sensitabs®, Rosco, Denmark). All the isolates tested were susceptible in vitro to amphotericin B and nearly all (97.2%) to itraconazole. In vitro susceptibility to fluconazole and ketoconazole was high (90.2% and 91.4% of isolates, respectively) but showed variations depending on the species tested. Resistance to fluconazole and ketoconazole was low in C. albicans (4% and 3%, respectively), but 30% of Candida guilliermondii and 36% of C. glabrata isolates were resistant to fluconazole. Ketoconazole resistance was observed in 40% of C. glabrata, and 17% of Candida tropicalis. Resistance to antifungal drugs is very low in Spain and it is related to non-C. albicans isolates.
KW - Agar diffusion
KW - Antifungal susceptibility
KW - Candida
KW - Cross-resistance
KW - Multicenter
KW - Spain
KW - Yeasts
M3 - Article
SN - 1130-1406
VL - 16
SP - 97
EP - 100
JO - Revista Iberoamericana de Micologia
JF - Revista Iberoamericana de Micologia
IS - 2
ER -